Citius Oncology, Inc. CTOR Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s total liabilities & equity?
- Citius Oncology, Inc. (CTOR) reported total liabilities & equity of $100.7M in Q1 2026.
- How has Citius Oncology, Inc.'s total liabilities & equity changed year-over-year?
- Citius Oncology, Inc.'s total liabilities & equity increased by 10.1% year-over-year, from $91.44M to $100.7M.
- What is the long-term trend for Citius Oncology, Inc.'s total liabilities & equity?
- Over 3 years (2022 to 2025), Citius Oncology, Inc.'s total liabilities & equity has grown at a 632.6% compound annual growth rate (CAGR), from $256.75K to $100.94M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.